Six species of *Schistosoma* trematodes are known to infect humans, but only *S. japonicum* is prevalent in China ([@R1]*,*[@R2]). However, because of enhanced international cooperation and communication, 2 *Schistosoma* species were identified from schistosomiasis cases imported to China: *S. haematobium* and *S. mansoni*. In addition, the *Biomphalaria straminea* snail, an intermediate host of *S. mansoni* trematodes, has been introduced into Shenzhen, Guangdong Province ([@R3],[@R4]), so the possibility exists that imported *S. mansoni* trematodes could be transmitted to these snails and result in locally acquired human infections. Therefore, we analyzed imported schistosomiasis status in China through data collected from the National Notifiable Disease Report System (NNDRS) during 2010--2018 to provide information for national policy making on schistosomiasis elimination.

We defined imported schistosomiasis as schistosomiasis in an endemic focus outside mainland China. A confirmed imported case had to meet both of the following diagnostic criteria: the patient was given a diagnosis of schistosomiasis, meaning that schistosome eggs or miracidia were detected in the patient's biological samples; the patient once traveled to and/or worked in schistosomiasis-endemic areas in other countries during transmission seasons ([Table](#T1){ref-type="table"}).

###### Imported schistosomiasis, mainland China, 2010--2018\*

  Diagnosis year   Reported province   Patient age, y   Source country   Activity/occupation   Parasite
  ---------------- ------------------- ---------------- ---------------- --------------------- ---------------------------
  2018             Jiangsu             45               Sudan            Businessman           *Schistosome haematobium*
  2018             Jiangsu             60               Sudan            Worker                *S. haematobium*
  2018             Jiangsu             55               Angola           Worker                *S. haematobium*
  2018             Jiangsu             49               Angola           Worker                *S. haematobium*
  2016             Beijing             34               Uganda           Civil servant         *S. mansoni*
  2016             Zhejiang            58               Nigeria          Farmer                *S. haematobium*
  2016             Zhejiang            56               Nigeria          Farmer                *S. haematobium*
  2016             Fujian              35               Angola           Housework             *S. haematobium*
  2016             Jiangxi             51               Zambia           Worker                *S. haematobium*
  2016             Sichuan             40               Unknown          Businessman           *S. haematobium*
  2015             Beijing             68               Cameroon         Retiree               Unknown
  2015             Beijing             35               Nigeria          Businessman           *S. mansoni*
  2015             Zhejiang            57               Nigeria          Worker                *S. haematobium*
  2015             Guangxi             45               Angola           Seafarer              *S. haematobium*
  2014             Shandong            43               Angola           Farmer                *S. haematobium*
  2012             Fujian              30               Unknown          Businessman           *S. haematobium*
  2012             Shanxi              46               Mali             Worker                Unknown
  2012             Shanxi              60               Angola           Worker                Unknown
  2010             Shanxi              56               Zambia           Worker                Unknown
  2010             Shanxi              55               Zambia           Worker                Unknown
  2010             Shanxi              39               Zambia           Worker                Unknown
  2010             Shanxi              42               Congo            Worker                Unknown

\*All cases occurred in men.

Twenty-two cases were reported during the study period. All imported cases occurred in men; their ages ranged from 30 to 68 years (mean 48 ± SD 9.98 years). Nineteen (86%) were 30--58 years of age, and 3 (14%) were \>58 years of age. Half of them were workers who returned to China from Africa; 4 (18%) were businessmen. No case was reported in Guangdong Province; 4 cases were reported in the neighboring provinces of Guangxi, Jiangxi, and Fujian.

The 22 cases acquired *Schistosoma* infection in 8 countries in Africa. Of the 20 case-patients for whom detailed data were available, most were infected in central Africa (Angola, 6 \[30%\] cases) and Cameroon and Congo (1 \[5%\] case each). In West Africa, Nigeria accounted for 6 (30%) cases and Mali for 1 (5%) case; in southern Africa, Zambia accounted for 4 (20%) cases.

More than 1 million persons from China are estimated to work in Africa ([@R5]). However, during the study period, only 22 confirmed cases were recognized. Considering the high risk for infection in Africa and the existing passive surveillance system, the number of imported schistosomiasis cases might be substantially underestimated.

As a national schistosomiasis surveillance system in China, NNDRS mirrors the local and imported case status passively reported on a national scale: when patients exposed in Africa had symptoms after returning to China, they sought treatment at hospitals on their own. If schistosomiasis was confirmed, the physician reported it to NNDRS, the only case report source in the existing surveillance system. However, this surveillance model has limitations. For example, cases might be misdiagnosed and missed because medical staff have insufficient clinical awareness of African schistosomiasis or because some patients may be asymptomatic or have mild symptoms.

Another challenge is that global integration has contributed to an increasing number of persons from China who travel abroad, and most persons who travel to Africa are not equipped with essential knowledge about schistosomiasis prevention and control. In addition, introduction of the *B. straminea* snail into southern China increases the risk that persons in China might acquire *S. mansoni* infection.

Because imported schistosomiasis may increase the disease burden in China and hinder the process of schistosomiasis elimination, several measures are urgently needed. First, a well-rounded active surveillance system needs to be integrated into the current monitoring model to ensure an accurate and quick response. When performing active surveillance through screening, sensitive and rapid immunologic tests should be widely conducted among the most susceptible group before etiologic examinations are conducted. Our results suggest that male workers returning from Africa are the most susceptible population. Meanwhile, because the intermediate host of African schistosomiasis, the *B. straminea* snail, has been introduced to Guangdong Province in southern China, persons returning from *S. mansoni*--endemic countries or regions. Guangdong Province and adjacent provinces should be a primary target population for surveillance. Identifying migrant workers as the highest priority group for active surveillance will be of great value. Second, China should collaborate with the World Health Organization and other relevant international institutions to evaluate the feasibility of existing serologic detection kits developed by China for diagnosis of imported schistosomiasis or develop new kits if necessary. Third, training programs on standardized clinical diagnostic criteria and normative case reporting operation are required in different types of healthcare organizations (e.g., hospitals, Centers for Disease Control and Prevention, entry and exit border stations) in mainland China to ensure accurate diagnosis and disease treatment. Other measures, such as multisector cooperation and coordination, could help achieve elimination of schistosomiasis in China.

*Suggested citation for this article*: Dai SM, Guan Z, Zhang LJ, Lv S, Cao CL, Li SZ, et al. Imported schistosomiasis, China, 2010--2018. Emerg Infect Dis. 2020 Jan \[*date cited*\]. <https://doi.org/10.3201/eid2601.191250>

This study was financially supported by the National Science and Technology Major Project (no. 2018ZX10101002-002, 2016YFC1202000).

Miss Dai is a junior researcher in the National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China. Her research interests include tropical diseases and epidemiology.
